A novel prognostic model based on ferritin and nomogram-revised risk index could better stratify patients with extranodal natural killer/T-cell lymphoma.
Xindi LiuYuanzheng LiangZiyuan ShenLiqiang WeiJing YangYingshi PiaoWei SangPengfei LiLiang WangPublished in: Cancer medicine (2023)
Serum ferritin level could be a novel prognostic factor in patients with ENKTCL. The new prognostic model combining NRI and clinical parameters could better predict the prognosis of ENKTCL, thereby warranting further validation and potentially guiding individualized treatment in future prospective clinical trials.